| Product Code: ETC9212516 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Lumasiran Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Lumasiran Market - Industry Life Cycle |
3.4 Serbia Lumasiran Market - Porter's Five Forces |
3.5 Serbia Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Serbia Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Serbia Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Serbia Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Serbia Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Serbia Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Serbia Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diseases treatable by Lumasiran in Serbia |
4.2.2 Growing awareness about the benefits and efficacy of Lumasiran therapy |
4.2.3 Favorable government regulations and policies supporting the adoption of innovative treatments |
4.3 Market Restraints |
4.3.1 High cost of Lumasiran treatment impacting affordability for patients |
4.3.2 Limited healthcare infrastructure and access to specialized treatment centers in certain regions of Serbia |
5 Serbia Lumasiran Market Trends |
6 Serbia Lumasiran Market, By Types |
6.1 Serbia Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Serbia Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Serbia Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Serbia Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Serbia Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Serbia Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Serbia Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Serbia Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Serbia Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Serbia Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Serbia Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Serbia Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Serbia Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Serbia Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Serbia Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Serbia Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Serbia Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Serbia Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Serbia Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Serbia Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Serbia Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Serbia Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Serbia Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Serbia Lumasiran Market Import-Export Trade Statistics |
7.1 Serbia Lumasiran Market Export to Major Countries |
7.2 Serbia Lumasiran Market Imports from Major Countries |
8 Serbia Lumasiran Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for Lumasiran therapy |
8.2 Number of healthcare professionals trained in administering Lumasiran treatment |
8.3 Rate of reimbursement approvals for Lumasiran therapy by health insurance providers |
8.4 Patient adherence and compliance rates to Lumasiran treatment regimen |
8.5 Number of partnerships and collaborations between pharmaceutical companies and healthcare institutions to promote Lumasiran therapy |
9 Serbia Lumasiran Market - Opportunity Assessment |
9.1 Serbia Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Serbia Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Serbia Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Serbia Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Serbia Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Serbia Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Serbia Lumasiran Market - Competitive Landscape |
10.1 Serbia Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Serbia Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here